Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:abcwangyong
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Anew research study evaluated the mechanisms of prostate cancer (PCa)resistance to androgen deprivation therapy (ADT) and progression to castrate-resistant disease.Using a coclinical approach,the investigators were able to identify key genetic determinant
期刊
Despite much recent progress,prostate cancer is still the most common malignancy in men of the Western world.Most prostate tumors are initially indolent,but some of them rapidly become aggressive and metastatic.The absence of an effective prognostic marke
期刊
Suppression of gonadal testosterone synthesis represents the standard ifrst line therapy for treatment of metastatic prostate cancer. However, in the majority of patients who develop castration-resistant prostate cancer (CRPC), it is possible to detect pe
期刊